FirmaIQ
Org.nr 985 889 635 First year · 2003 Year-over-year analysis

LYTIX BIOPHARMA ASA: årsregnskap 2003 (first published accounts)

First published accounts

Full company analysis · All year comparisons

Summary

What changed

First year in the published series for LYTIX BIOPHARMA ASA (2003). No prior-year comparative in this dataset.

Also worth watching: first net result; opening equity; cash at year-end. All figures are taken from the published annual accounts for LYTIX BIOPHARMA ASA.

At a glance

Scorecard

Revenue
— n/m
—
Net result
— +770 NOK
—
Equity
— 55 NOK
—
Cash
— 390 NOK
—

Baseline figures

  • ·

    First net result

    Net result +770 NOK. Reported fact

  • ·

    Opening equity

    Book equity 55 NOK. Reported fact

  • ·

    Cash at year-end

    Cash 390 NOK. Reported fact

  • ·

    Paid-in capital

    Paid-in equity 825 NOK. Reported fact